1.Yang Tian, Chang Na, Qi Sun, Chunyun Zhao, Wentao Zhang, Yan Su, Dong Mei, Yitong Liu, Jingyi Ye, Yingdong Ma, Shuxin Luo, Muhan Zhang, Yanqi Wang, Shuang Zhang*, Chunying Cui*. BBB-Penetrating Biomimetic Nanoparticles Orchestrate STING Activation and Metabolic Immunomodulation for Potent Glioma Immunotherapy. Nano Today, 2026, accept. 2.XiaoXuan Hong, Xianfu Li, Xiaolu Han, Jinghu Lou, Yue Li, Jintao Lin, Yi Cheng, Haonan Xing, Hui Zhang, Xiwei Wang, Shuang Zhang, Nan Liu, Zengming Wang, Chunying Cui*, Zheng Aiping*. An innovative and stable mRNA-LNP microneedle vaccine elicits humoral and multifunctional cellular immune responses. Acta Pharmaceutica Sinica B, 2026，16(1), 503. 3.Jie Zhang, Qi Sun, Yaoqi Wang, Dong Mei, Xiaoling Wang, Yan Su, Yang Tian, Ran Huo, Danni Liu, Siyu Liu, Myagmarsuren Baldan, Shuang Zhang*, Chunying Cui*. Cancer cell membrane-camouflaged pH-responsive nanoparticles for enhancing siRNA effect and synergistic anti-tumor therapy. Journal of Nanobiotechnology, 2025, 23: 471. 4.Qi Sun*, Yuyan Wang, Hetian Ren, Shiyuan Hou, Kaiyi Niu, Liu Wang, Siyu Liu, Jingyi Ye, Chunying Cui*, Xianrong Qi*.Engineered Hollow Nanocomplex Combining Photothermal and Antioxidant Strategies for Targeted Tregs Depletion and Potent Immune Activation in Tumor Immunotherapy. Adv Healthc Mater, 2025，14(15), e2405124. 5.Myagmarsuren Baldan, Shuang Zhang, Qi Sun, Yan Su, Dong Mei, Ran Sun, Ao Zheng, Danni Liu, Jie Zhang, Ran Huo, Yang Tian3, Le Han, Shibo Wang3, Yaoqi Wang*, Chunying Cui*. NIR-Triggered siRNA Release and Lysosomal Escape for Synergistic Photothermal Tumor Therapy. Int J Nanomedicine, 2025，20(0), 4863. 6.Danni Liu, Yaoqi Wang, Qi Sun, Dong Mei, Xiaoling Wang, Yan Su, Jie Zhang, Ran Huo, Yang Tian, Siyu Liu, Shuang Zhang, Chunying Cui*. Iron and siRNA co-encapsulated ferritin nanocages induce ferroptosis synergistically for cancer therapy. Acta Pharmaceutica Sinica B, 2025, 15(1): 526. 7.Ning Yang, Qi Sun, Yaoqi Wang, Dong Mei, Xiaoling Wang, Jie Zhang, Danni Liu, Ran Huo, Yang Tian, Yan Su, Shuang Zhang*, Chunying Cui*. Endosomal disruption by co-encapsulating gentamicin in lipid nanoparticles for efficient siRNA delivery and cancer therapy. Asian Journal of Pharmaceutical Sciences, 2025, 20(3): 101011. 8.Yunpeng Zhang, Danni Liu, Yaoqi Wang, Qi Sun, Dong Mei, Xiaoling Wang,Yan Su, Siyu Liu, Chunying Cui*, Shuang Zhang*. High-Density Lipoprotein Biomimetic Inorganic–Organic Composite Nanosystem for Atherosclerosis Therapy. Polymers. 2025, 17: 625. 9.Jingru Li, Haonan Xing, Fan Meng, Ting Liu, Xiaoxuan Hong, Xiaolu Han, Yuhan Dong, Meng Li, Zengming Wang, Shuang Zhang, Chunying Cui*, Zheng Aiping*. Virus-Mimetic Extracellular-Vesicle Vaccine Boosts Systemic and Mucosal Immunity via Immune Recruitment. ACS Nano. 2024, 18: 19498. 10.Ran Sun, Yaoqi Wang, Qi Sun, Yan Su, Jie Zhang, Danni Liu, Ran Huo, Yang Tian, Myagmarsuren Baldan, Shuang Zhang*，Chunying Cui*. MMP-2 Responsive Gold Nanorods Loaded with HSP-70 siRNA for Enhanced Photothermal Tumor Therapy. Molecular Pharmaceutics, 2024, 21: 5455. 11.Dandan Li, Danni Liu, Yaoqi Wang, Qi Sun, Ran Sun, Jie Zhang, Xiaoxuan Hong, Ran Huo, Shuang Zhang*, Chunying Cui*. Multifunctional liposomes Co-encapsulating epigallocatechin-3-gallate (EGCG) and miRNA for atherosclerosis lesion elimination. Nanoscale Adv, 2024, 6(1): 221. 12.Si Chen, Shuang Zhang, Yifan Wang, Xin Yang, Hong Yang*, Chunying Cui*. Anti-EpCAM Functionalized Graphene Oxide Vector for Tumor Targeted siRNA Delivery and Cancer Therapy. Asian Journal of Pharmaceutical Sciences, 2021, 16: 598. 13.Xin Yang, Yifan Wang, Si Chen, Shuang Zhang*, ChunyingCui*. Cetuximab modified human serum albumin nanoparticles co-Loaded with doxorubicin and MDR1 siRNA for the treatment of drug-resistant breast. Int J Nanomedicine. 2021 Oct 14;16:7051. 14.Yifan Wang, Si Chen, Xin Yang, Shuang Zhang*, Chunying Cui*. Preparation Optimization of Bovine Serum Albumin Nanoparticles and Its Application for siRNA Delivery. Drug Design Development and Therapy, 2021, 15: 1531. 15.Jing Li, Xu Ge, Chunying Cui*, Yifan Zhang, Yifan Wang, Xiaoli Wang, Qi Sun. Preparation and Characterization of Functionalized Graphene Oxide Carrier for siRNA Delivery. Int J Mol Sci. 2018 Oct 17;19(10). pii: E3202. doi: 10.3390/ijms19103202. 16.Xiaoli Wang, Qi Sun, Chunying Cui*, Jing Li, Yifan Wang. Anti-HER2 functionalized raphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo. Drug Design, Development and Therapy. 2018:12 2841. 17.Qi Sun, Xiaoli Wang, Chunying Cui*, Jing Li, Yifan Wang. Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo. Int J Nanomedicine. 2018 Jun 27;13:3713. 18.Lulu Ren, Yifan Zhang, Chunying Cui*, Yanzhao Bi and Xu Ge. Functionalized graphene oxide for anti-VEGF siRNA delivery: preparation, characterization and evaluation in vitro and in vivo. RSC Adv., 2017,7, 20566. 19.Yanzhao Bi, Yifan Zhang, Chunying Cui*, Lulu Ren, Xueyun Jiang. Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7. Int J Nanomedicine. 2016,11:5771. 20.Wen Zhao, Yifan Zhang, Xueyun Jiang, Chunying Cui*. Design, synthesis and evaluation of VEG F-siRNA /CRS as a novel vector for gene delivery. Drug Design, Development and Therapy. 2016,10:3851-3865 21.Chunying Cui, Yaonan Wang, Wen Zhao, Kaikai Yang, Xueyun Jiang, Shan Li, Ming Zhao, Yuanbo Song and Shiqi Peng*. RGDS covalently surfaced nanodiamond as a tumor targeting carrier of VEGF-siRNA: synthesis, characterization and bioassay. J. Mater. Chem. B , 2015,3：9260-9268 22.Chunying Cui, Yuji Wang, Kaikai Yang, Yaonan Wang, Junyu Yang, Jianzhong Xi, Ming Zhao*, Jianhui Wu, and Shiqi Peng*. Preparation and Characterization of RGDS/Nanodiamond as a Vector for VEGF-siRNA Delivery. J. Biomed. Nanotechnol . 2015,11: 70-80 23Cui Chunying, Wang Y, Wang Y, Zhao M*, Peng S*. Exploring the Relationship between the Inhibition Selectivity and the Apoptosis of Roscovitine-Treated Cancer Cells. J Anal Methods Chem. 2013;2013:389390. doi: 10.1155/2013/389390. Epub 2013 Apr 4. 24.Cui Chunying, Wang Y, Wang Y, Zhao M*, Peng S*. Alsterpaullone, a Cyclin-Dependent Kinase Inhibitor, Mediated Toxicity in HeLa Cells through Apoptosis-Inducing Effect. Journal of Analytical Methods in Chemistry Volume (2013), ttp://dx.doi.org/10.1155/2013/602091 25.Wang F#, Cui Chunying#, Ren Z, Wang L, Liu H, Cui G*. Preparation and biological evaluation of tumor-specific Ara-C liposomal preparations containing RGDV motif. J Pharm Sci . 2012 Dec;101(12):4559-68. 26.Du H#, Cui Chunying#, Wang L, Liu H, Cui G*. Novel Tetrapeptide, RGDF, Mediated Tumor Specific Liposomal Doxorubicin (DOX) Preparations.Mol Pharm . 2011 Aug 1;8(4):1224-32. 27.Chunying Cui, Yunwei Zhang, Lili Wang, Hu Liu and Guohui Cui*. Enhanced anticancer activity of glutamate prodrugs of all-trans retinoic acid. Journal of Pharmacy and Pharmacology 2009; 61: 1353–1358. 28.Song N, Zhao M, Wang Y, Hu X, Wu J, Jiang X, Li S, Cui C, Peng S*. Nanomedical strategy to prolong survival period, heighten cure rate, and lower systemic toxicity of S180 mice treated with MTX/MIT. Drug Des Devel Ther. 2016 Aug 30;10:2701-11. 29.Lv X, Zhao M, Wang Y, Hu X, Wu J, Jiang X, Li S, Cui C, Peng S*. Loading cisplatin onto 6-mercaptopurine covalently modified MSNS: a nanomedicine strategy to improve the outcome of cisplatin therapy. Drug Design, Development and Therapy.2016,10:3933-3946 30.Meng Q, Yu X, Li C, Zhang C, Cui C, Luo D*. Possible mechanisms underlying the biphasic regulatory effects of arachidonic acid on Ca2+ signaling in HEK293 cells.Chen L, Cell Signal. 2012 Aug;24(8):1565-72. Epub 2012 Mar 30. 31.Liu Boyang, Chunying, Cui, guohuiCui*. Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-beta- arabinofuranosylcytosine. Eur J Med Chem 2009, Sep, 01;44(9):3596-600 132.Wen-Son Hsieh, Ross Soo, Bee-Keow Peh, Thomas Loh, Difeng Dong, Donny Soh, Lim-Soon Wong, Simon Green, Judy Chiao, Chunying Cui, Yoke-Fong Lai, Soo-Chin Lee, Benjamin Mow, Richie Soong, Manuel Salto-Tellez and Boon-Cher Goh*. Pharmacodynamic Effects of Seliciclib (R-Roscovitine, CYC202) in Patients with Undifferentiated Nasopharyngeal Cancer (NPC) Using a Window Trial Design. Cancer research. Clinical Cancer Research. 2009 February 15, 15：1435 33.Chun-Ying Cui, Wan-Liang Lu, Lan Xiao, Qiang Zhang*. Sublingual Delivery of Insulin: Effects of Enhancers on the Mucosal Lipid Fluidity and Protein Conformation, the Transport, and the In Vivo Hypoglycemic Activity. Biological & Pharmaceutical Bulletin, Vol 28 (12)：2279-2288, 2005. |
